http://ipkitten.blogspot.com/2025/05/first-upc-decision-to-tackle.html
The complexities of patenting new uses for known medical substances were recently considered by the Düsseldorf Local Division in the UPC’s first decision on second medical use claims. The case of Sanofi v Amgen (UPC_CFI_505/2024) specifically addressed the novelty and infringement standards applicable to second medical use claims. The case is part of the long-running dispute
Content reproduced from The IPKat as permitted under the Creative Commons Licence (UK).
